Log in
/
Register
Home
Overview
Upload / Manage Data
Browse / Search Studies
Analyze Studies
Tutorials
FAQ
Data Repository
Overview
Upload / Manage Studies
Browse / Search Studies
Analyze Studies
Data Sharing Policy
Tutorials
FAQ
Databases
Overview
Metabolite Database
Human Metabolome Gene/Protein Database (MGP)
RefMet: Reference List of Metabolite Names
External Metabolomics Databases (Links)
Protocols
Overview
General Protocols
Study-specific Protocols
Tools
Overview
Load and analyze your own dataset
Analyze Studies
MS Searches
Structure drawing
REST Service
External Tools (Links)
About
Overview
Publishing Partners
How to Cite
How to Link
Terms of Use
Personnel
Contact
Sitemap
Search
Keyword Search
Advanced Searches
Return to Statistics Toolbox
Correlation analysis for Study ST003364
Nodes mapped to fold-change between 2 conditions
Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1
Experimental factor
Group2
Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed (45)
Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed (21)
Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (21)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS10 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS11 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS12 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS13 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS14 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS15 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS16 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS17 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS18 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS19 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS1 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS20 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS21 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS22 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS23 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS24 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS25 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS26 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS27 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS28 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS29 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS2 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS30 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS31 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS32 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS33 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS34 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS35 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS36 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS37 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS38 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS39 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS3 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS40 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS41 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS42 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS43 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS44 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS4 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS5 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS6 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS7 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS8 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS9 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:female | Pathology:calcific (4)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:female | Pathology:fibrotic (4)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:female | Pathology:mildly diseased (2)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:male | Pathology:fibrotic (1)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:male | Pathology:mildly diseased (1)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed (21)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:female | Pathology:calcific (4)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:female | Pathology:fibrotic (4)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:female | Pathology:mildly diseased (4)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:male | Pathology:calcific (5)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:male | Pathology:fibrotic (5)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:male | Pathology:mildly diseased (5)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:calcific (6)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:fibrotic (8)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:mildly diseased (4)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific (11)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:fibrotic (10)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:mildly diseased (4)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (6)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:calcific (9)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:fibrotic (9)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:mildly diseased (6)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:calcific (9)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:fibrotic (10)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:mildly diseased (8)
Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids identification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (15)
Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:calcific (6)
Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:fibrotic (8)
Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:mildly diseased (4)
Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific (11)
Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:fibrotic (10)
Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:mildly diseased (4)
Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (31)
Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:calcific (9)
Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:fibrotic (9)
Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:mildly diseased (6)
Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:calcific (9)
Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:fibrotic (10)
Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:mildly diseased (8)
Analysis:
Reversed phase(C30) NEGATIVE ION MODE
Reversed phase(C30) UNSPECIFIED ION MODE
Reversed phase(C30) POSITIVE ION MODE
Reversed phase(C18) NEGATIVE ION MODE
Combine data for all analyses?:
Metabolomics Workbench
Terms of use
Site map
Contact